Susceptibility of human leukemia cells to allogeneic and autologous lymphokine-activated killer cells and its augmentation by exposure of leukemia target cells to cytotoxic drugs in vitro and in vivo.
Teichmann
J V
JV
Department of Hematology and Oncology, Universitätsklinikum Steglitz, Free University of Berlin, Fed. Rep. of Germany.
Ludwig
W D
WD
Thiel
E
E
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003602:Cytotoxicity, Immunologic; D006801:Humans; D007376:Interleukin-2 / Q000627:therapeutic use; D015979:Killer Cells, Lymphokine-Activated / Q000276:immunology*; D007938:Leukemia / Q000276:immunology / Q000628:therapy*
D000970:Antineoplastic Agents; D007376:Interleukin-2